...
首页> 外文期刊>BMC Infectious Diseases >Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study
【24h】

Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study

机译:严重发烧血小板减少症综合征(SFT)的临床特征 - 分配脑炎/脑病:回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Severe fever with thrombocytopenia syndrome (SFTS) cause encephalitis/encephalopathy, but few reports were available. We aimed to investigate the incidence of encephalitis/encephalopathy in SFTS patients and to summarize clinical characteristics, laboratory findings and imaging features. We conducted a retrospective review of all patients with confirmed SFTS admitted to Nanjing Drum Tower Hospital, a tertiary hospital in Nanjing City, China, between January 2016 and July 2020. The patients were divided into two groups according to whether they had encephalitis/encephalopathy: encephalitis/encephalopathy group and non- encephalitis/encephalopathy group. Clinical data, laboratory findings, imaging characteristics, treatments and outcomes of these patients were collected and analyzed. A total of 109 SFTS patients with were included, of whom 30 (27.5?%) developed encephalitis/encephalopathy. In-hospital mortality (43.3?%) was higher in encephalitis/encephalopathy group than non-encephalitis/encephalopathy group (12.7?%). Univariate logistic regression showed that cough, wheezing, dyspnoea, respiratory failure, vasopressors use, bacteremia, invasive pulmonary aspergillosis (IPA) diagnoses, PCT??0.5 ug/L, CRP??8?mg/L, AST??200?U/L and serum amylase level??80?U/L were the risk factors for the development of encephalitis/encephalopathy for SFTS patients. Multivariate logistic regression analysis identified bacteremia, PCT??0.5?mg/L and serum amylase level??80?U/L as independent predictors of encephalitis/ encephalopathy development for SFTS patients. SFTS-associated encephalitis/encephalopathy has high morbidity and mortality. it was necessary to strengthen the screening of CSF testing and brain imaging after admission for SFTS patients who had symptoms of encephalitis/encephalopathy. SFTS patients with bacteremia, PCT??0.5?ug/L or serum amylase level??80?U/L should be warned to progress to encephalopathy.
机译:血小板减少症综合征(SFT)严重发烧原因脑炎/脑病,但有很少的报告。我们的目标是调查SFTS患者中脑炎/脑病的发病率,总结临床特征,实验室发现和成像特征。我们在2016年1月至7月20日期间,对南京市大专院校南京鼓楼医院录取南京鼓楼医院的所有患者的回顾性审查。患者根据是否有脑炎/脑病,患者分为两组:脑炎/脑病组织和非脑炎/脑病组织。收集并分析了这些患者的临床资料,实验室发现,成像特征,治疗和结果。共有109例SFTS患者,其中30名(27.5?%)发育脑炎/脑病。脑炎/脑病组中的医院内死亡率(43.3?%)高于非脑炎/脑病组(12.7%)。单变量逻辑回归表明,咳嗽,喘息,呼吸困难,呼吸衰竭,血管加压剂使用,菌血症,侵袭性肺曲线症(IPA)诊断,PCT?&?0.5 Ug / L,CRP?8?Mg / L,AST? & 200?U / L和血清淀粉酶水平?&?80?U / L是SFTS患者脑炎/脑病发展的危险因素。多变量物流回归分析鉴定菌血症,PCT?&&?0.5?mg / l和血清淀粉酶水平?&α0≤u/ l作为sfts患者的脑炎/脑病发育的独立预测因子。 SFTS相关的脑炎/脑病发病率高,死亡率高。有必要加强CSF测试和脑成像的筛查,患有脑炎/脑病症状的SFTS患者。患有菌血症的患者,PCTα&α0.5?UG / L或血清淀粉酶水平?&α0≤u/ l应警告以进展到脑病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号